ASX:RCE – China Patent Acceptance Strengthens Global Anti-Infective Portfolio
Recce Pharmaceuticals has secured patent acceptance in China for its synthetic anti-infectives technology, extending protection until 2041 and expanding access…
No financial advise, DYOR
Recce Pharmaceuticals has secured patent acceptance in China for its synthetic anti-infectives technology, extending protection until 2041 and expanding access…
Circus SE has successfully acquired FullyAI, establishing a unified intelligence layer across its robotics and software ecosystem, marking a significant…
NVIDIA announces the establishment of G-QuAT and the launch of ABCI-Q, marking a significant advancement in quantum-GPU computing capabilities. This…
We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.